## LRCX: Lam Research Corporation - XLK: Technology

### Executive Summary

No thesis match: MRS_20 1.9% below STRENGTH zone (4.0-10.0%); PEG 2.20 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($146.37)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Stocks making big moves yesterday: Lam Research, Sweetgreen, Applied Materials, Lattice Semiconductor, and The Pennant Group**
- Source: Finviz | 20251203T080000 | Bullish | Relevance: 100%
- This article details the significant stock movements of five companies on Tuesday: Lam Research, Sweetgreen, Applied Materials, Lattice Semiconductor, and The Pennant Group. Each company experienced a rise in stock value due to various positive developments, including analyst upgrades, raised price targets, expansion news, and strong "Buy" ratings. The report highlights the specific catalysts behind each company's stock appreciation.

**2. Scotia Capital Inc. Sells 9,284 Shares of Lam Research Corporation $LRCX**
- Source: MarketBeat | 20251202T122309 | Neutral | Relevance: 100%
- Scotia Capital Inc. reduced its stake in Lam Research Corporation ($LRCX) by 45% in the second quarter, selling 9,284 shares and retaining 11,362 shares valued at $1.11 million. This comes as Lam Research reported strong earnings, beating revenue and EPS estimates, and provided positive Q2 2026 guidance. Insider selling has been significant, with 102,608 shares offloaded in the past three months, reducing insider ownership to 0.31%.

**3. Lam Research (LRCX) Stock Is Up, What You Need To Know**
- Source: Finviz | 20251202T111100 | Somewhat-Bullish | Relevance: 100%
- Shares of Lam Research (NASDAQ:LRCX) jumped 2.9% after Morgan Stanley raised its price target to $158 from $137, maintaining an "Equalweight" rating. This optimistic outlook on the semiconductor equipment maker's valuation comes amidst renewed investor interest and strong financial performance. The stock's performance reflects its volatility and the market's positive, yet cautious, reception to significant news, like the broader tech sector uplift driven by AI developments and potential interest rate cuts.

**4. Panagora Asset Management Inc. Acquires 11,461 Shares of Lam Research Corporation $LRCX**
- Source: MarketBeat | 20251201T125211 | Bullish | Relevance: 100%
- Panagora Asset Management Inc. increased its stake in Lam Research Corporation by 1.4% in Q2, acquiring 11,461 shares to reach a total of 832,578 shares worth approximately $81.0 million. Other major institutional investors like Norges Bank and Vanguard also made significant moves, with institutions collectively owning about 84.61% of the semiconductor company's stock. Analysts currently hold a "Moderate Buy" consensus rating for Lam Research with a target price of $152.17, following a positive Q1 EPS beat and strong revenue growth.

**5. Lam Research Corp. stock outperforms competitors on strong trading day**
- Source: MarketWatch | 20251203T163400 | Bullish | Relevance: 100%
- Lam Research Corp. stock (LRCX) rose 1.15% to $159.75 on Wednesday, outperforming its competitors during a strong trading day for the broader market. This marks the second consecutive day of gains for the stock, as the S&P 500 Index (SPX) and Dow Jones Industrial Average (DJIA) also posted gains. The article highlights LRCX's positive performance in an overall bullish market.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Morgan Stanley | $158 | $137 | +15% |
| 2025-11-25 | UBS | $175 | $165 | +6% |
| 2025-11-12 | Citigroup | $190 | $175 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Morgan Stanley | main | Equal-Weight |
| 2025-11-25 | UBS | main | Buy |
| 2025-11-12 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 12 ($2.00M) |
| Sells | 6 ($14.54M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (+0.3%)
- Blackrock Inc.: 9.9% (+1.7%)
- JPMORGAN CHASE & CO: 4.8% (+47.4%)
- State Street Corpora: 4.8% (+0.4%)
- Geode Capital Manage: 2.7% (-0.5%)

### Key Risks

1. Heavy insider selling: $15M sold (6 transactions in 90 days).
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +10%) could attract flows.
- Momentum building: MRS_20 improving +2.1% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.20 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 62%, ROA 20%, margin 30%). Balance sheet: strong liquidity (2.2x), $1.6B free cash flow. Analyst sentiment positive (3 raises, avg +10%). Insider selling cluster ($14.5M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $224.6B |
| Beta | 1.78 |
| 52W Range | $56.32 - $179.80 |
| Short Interest | 2.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.20 |
| Forward P/E | 28.3 |
| Current P/E | 33.0 |
| YoY Growth | 16.3% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -0.2% to 1.9% (+2.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.1pp (needs >4.0% for momentum thesis). MRS_5 at 1.6% confirms short-term momentum alignment. AM_20 at 3.8% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 58. OFD pattern: +SLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.92% (CS: 70) | Neutral |
| RSI_14 | 58.2 | Neutral |
| MACD Histogram | 0.38 | Bullish |
| vs SMA20 | 1.036x | Above |
| vs SMA50 | 1.077x | Above |
| vs SMA200 | 1.542x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $159.75
- **Stop Loss:** $146.37 (8.4% risk)
- **Target:** $173.13 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 71
- **Position Value:** $11,342.25
- **Portfolio %:** 11.34%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-01-28 (Est: $1.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.22 | $1.26 | +3.3% |
| 2025Q2 | $1.21 | $1.33 | +10.4% |
| 2025Q1 | $1.00 | $1.04 | +4.1% |
| 2024Q4 | $0.88 | $0.91 | +3.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*